Search
for
Sort by
Research 541–570 of 560
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Native and engineered extracellular vesicles for wound healing
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Biological therapy in the treatment of melanoma
- Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis
- Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- Author response: scRNA+TCR-seq reveals the proportion and characteristics of dual TCR Treg cells in mouse lymphoid and non-lymphoid tissues
- Exploring murE protein inhibitors of Tropheryma whipplei through pharmacoinformatic approaches incorporating solubility-enhancing formulation insights
- Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Morphogenesis of chimeric hair follicles in engineered skin substitutes with human keratinocytes and murine dermal papilla cells
- Fabrication of Chimeric Hair Follicles for Skin Tissue Engineering
- Hair Follicle Regeneration Using Grafted Rodent and Human Cells
- <i>In vivo</i> alteration of the keratin 17 gene in hair follicles by oligonucleotide‐directed gene targeting
- In vivo Alteration of the Keratin 17 Gene in Hair Follicles by Oligonucleotide-directed Gene Targeting
- Characterization of Hair Follicle Development in Engineered Skin Substitutes
- Hair Follicle Organoids Using Human iPSC-Derived Ectodermal Precursor Cells for Hair Regenerative Medicine
- Hair regeneration: Mechano-activation and related therapeutic approaches.
- Contribution of GFP Expressing Dermal Papillae Cells to the Formation of Chimeric Embryos and their Survival in Uterine Environment
- Skin Wound Healing